Table 1.

Summary of previous fibroblast bioluminescence reporter studies assessing molecular rhythmicity from healthy controls or bipolar patients.

Subject	n	Gene	Period (h)	Publication
Control	19	Bmal1	24.5 ± 0.75 (s.d.)	Brown et al. [23]
Control	28	Bmal1	24.5 ± 0.75 (s.e.m.)	Brown et al. [25]
	9		24.71 ± 0.38 (s.e.m.)	Pagani et al. [24]
Control	11	Bmal1	24.77 ± 0.42 (s.e.m.)	Pagani et al. [24]
	8		24.46 ± 0.48 (s.e.m.)	Pagani et al. [24]
Control	19	Per2	25.10 ± 0.20 (s.e.m.)	McCarthy et al. [26]
BD	19		25.50 ± 0.20 (s.e.m.)a	McCarthy et al. [26]
Control	12	Bmal1	25.50 ± 0.60 (s.d.)	Bamne et al. [27]
BD	13		26.30 ± 1.20 (s.d.)	Bamne et al. [27]

^aIndicates a significant difference.